Condensed Consolidated Statements of Changes In Equity (Deficiency) (Unaudited) - USD ($)		PrefePreferred	CommCommon		Additional paid-in capital	Subscription receivable	Accumulated deficit	Accumulated other comprehensive loss	Non-controlling interest	Shares to be issued	Accumulated other comprehensive loss	Total
Balance at Jun. 30, 2020			$ 28,414,992		$ 2,334,962	$ (59,869)	$ (23,421,594)	$ (1,084,030)	$ (6,542,361)			$ (357,900)
Balance (in Shares) at Jun. 30, 2020			3,718,788	[1]
Issuance of common stock to private investors			$ 1,051,200			59,869						1,111,069
Issuance of common stock to private investors (in Shares)	[1]		720,000
Foreign currency translation								191,251	(198,824)			(7,573)
Net income (loss)							(733,791)		(14,665)			(748,456)
Balance at Sep. 30, 2020			$ 29,466,192		2,334,962		(24,155,385)	(892,779)	(6,755,850)			(2,860)
Balance (in Shares) at Sep. 30, 2020			4,438,788	[1]
Balance at Jun. 30, 2020			$ 28,414,992		2,334,962	(59,869)	(23,421,594)	(1,084,030)	(6,542,361)			(357,900)
Balance (in Shares) at Jun. 30, 2020			3,718,788	[1]
Net income (loss)												(5,360,965)
Balance at Mar. 31, 2021			$ 82,555,700		2,334,962		(28,739,565)	(733,247)	(6,969,926)			48,447,924
Balance (in Shares) at Mar. 31, 2021			14,961,999	[1]
Balance at Sep. 30, 2020			$ 29,466,192		2,334,962		(24,155,385)	(892,779)	(6,755,850)			(2,860)
Balance (in Shares) at Sep. 30, 2020			4,438,788	[1]
Issuance of preferred stock to private investor		$ 1,427,600										1,427,600
Issuance of preferred stock to private investor (in Shares)		860,000
Issuance of common stock to private investors			$ 4,322,330									4,322,330
Issuance of common stock to private investors (in Shares)	[1]		1,560,000
Foreign currency translation								235,865	(204,827)			31,038
Net income (loss)							(1,102,919)		9,359			(1,093,560)
Balance at Dec. 31, 2020		$ 1,427,600	$ 33,788,522		2,334,962		(25,258,304)	(656,914)	(6,951,318)			4,684,548
Balance (in Shares) at Dec. 31, 2020		860,000	5,998,788	[1]
Issuance of common stock to private investors			$ 42,535,678									42,535,678
Issuance of common stock to private investors (in Shares)	[1]		6,740,456
Conversion of preferred stock into common stock		$ (1,427,600)	$ 1,427,600
Conversion of preferred stock into common stock (in Shares)		(860,000)	860,000	[1]
Cashless exercise of stock warrants			$ 4,803,900									4,803,900
Cashless exercise of stock warrants (in Shares)	[1]		1,362,755
Foreign currency translation								(76,333)	19,080			(57,253)
Net income (loss)							(3,481,261)		(37,688)			(3,518,949)
Balance at Mar. 31, 2021			$ 82,555,700		2,334,962		(28,739,565)	$ (733,247)	(6,969,926)			48,447,924
Balance (in Shares) at Mar. 31, 2021			14,961,999	[1]
Balance at Jun. 30, 2021			$ 82,555,700		2,334,962		(34,321,762)		(7,415,631)		$ (729,096)	42,424,173
Balance (in Shares) at Jun. 30, 2021			15,132,113	[1]
Stock compensation issue to employee			$ 2,927,400									2,927,400
Stock compensation issue to employee (in Shares)	[1]		1,020,000
Foreign currency translation									(7,969)		625,730	617,761
Foreign currency translation (in Shares)	[1]
Net income (loss)							(4,961,180)		(256,202)			(5,217,382)
Net income (loss)	[1]
Balance at Sep. 30, 2021			$ 85,483,100		2,334,962		(39,282,942)		(7,679,802)		(103,366)	40,751,952
Balance (in Shares) at Sep. 30, 2021	[1]		16,152,113
Balance at Jun. 30, 2021			$ 82,555,700		2,334,962		(34,321,762)		(7,415,631)		(729,096)	42,424,173
Balance (in Shares) at Jun. 30, 2021			15,132,113	[1]
Net income (loss)												(23,455,465)
Balance at Mar. 31, 2022			$ 94,950,808		2,334,962		(57,473,576)		(1,629,965)		(215,985)	37,966,244
Balance (in Shares) at Mar. 31, 2022	[1]		21,980,333
Balance at Sep. 30, 2021			$ 85,483,100		2,334,962		(39,282,942)		(7,679,802)		(103,366)	40,751,952
Balance (in Shares) at Sep. 30, 2021	[1]		16,152,113
Stock compensation issue to former director			$ 377,000									377,000
Stock compensation issue to former director (in Shares)	[1]		100,000
Issuance of common stock to private investors										4,563,908		4,563,908
Issuance of common stock to private investors (in Shares)	[1]		1,400,000
Foreign currency translation									34,199		(375,955)	(341,756)
Foreign currency translation (in Shares)	[1]
Disposal of VIE and subsidiaries									5,919,050			5,919,050
Disposal of VIE and subsidiaries (in Shares)	[1]
Net income (loss)							(8,760,575)		(54,988)			(8,815,563)
Net income (loss)	[1]
Balance at Dec. 31, 2021			$ 85,860,100		2,334,962		(48,043,517)		(1,781,541)	4,563,908	(479,321)	42,454,591
Balance (in Shares) at Dec. 31, 2021	[1]		17,652,113
Issuance of common stock to private investors			$ 4,563,908							$ (4,563,908)
Issuance of common stock to private investors (in Shares)	[1]
Warrant repurchase			$ (7,948,000)									(7,948,000)
Warrant repurchase (in Shares)	[1]
Issuance of common stock to private placement			$ 5,961,911									5,961,911
Issuance of common stock to private placement (in Shares)	[1]		2,328,807
Stock based compensation to employee			$ 2,740,000									2,740,000
Stock based compensation to employee (in Shares)	[1]		500,000
Stock based compensation to consultants			$ 3,772,889									3,772,889
Stock based compensation to consultants (in Shares)	[1]		900,000
Cashless exercise of stock warrants
Cashless exercise of stock warrants (in Shares)	[1]		599,413
Foreign currency translation									144,037		263,336	407,373
Foreign currency translation (in Shares)	[1]
Net income (loss)							(9,430,059)		7,539			(9,422,520)
Net income (loss)	[1]
Balance at Mar. 31, 2022			$ 94,950,808		$ 2,334,962		$ (57,473,576)		$ (1,629,965)		$ (215,985)	$ 37,966,244
Balance (in Shares) at Mar. 31, 2022	[1]		21,980,333

[1] Shares and per share data are presented on a retroactive basis to reflect the 1-for-5 reverse stock split on July 7, 2020.